DAA1222 |
RELN promoter methylation increase |
RELN |
— |
brain, cerebral cortex |
Human |
|
DAA1223 |
APOE promoter methylation decrease |
APOE |
— |
prefrontal cortex |
Human |
|
DAA1224 |
MTHFR methylation decrease |
— |
— |
prefrontal cortex |
Human |
|
DAA123 |
hypothetical protein LOC552889 |
|
3.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA1231 |
decreased NF-KappaB induction in T cells |
— |
— |
T cell |
Human |
|
DAA1232 |
decreased proteasomal activity in T cells |
— |
— |
T cell |
Human |
|
DAA124 |
chromosome 5 open reading frame 30 |
C5orf30 |
19.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA125 |
programmed cell death 4 (neoplastic transformation inhibitor) |
PDCD4 |
12.0% Increase Gene Expression Level |
brain |
Human |
|
DAA126 |
lipid phosphate phosphatase-related protein type 4 |
LPPR4 |
10.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA127 |
leucine-rich repeats and immunoglobulin-like domains 1 |
LRIG1 |
13.0% Increase Gene Expression Level |
brain |
Human |
|
DAA128 |
latent transforming growth factor beta binding protein 1 |
LTBP1 |
19.0% Increase Gene Expression Level |
brain |
Human |
|
DAA129 |
microtubule-associated protein 2 |
MAP2 |
20.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA13 |
apolipoprotein D |
APOD |
14.0% Increase Gene Expression Level |
brain |
Human |
|
DAA130 |
mitogen-activated protein kinase kinase 1 |
MAP2K1 |
7.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA131 |
mitogen-activated protein kinase 1 |
MAPK1 |
17.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA132 |
mitogen-activated protein kinase 9 |
MAPK9 |
15.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA133 |
microtubule-associated protein tau |
MAPT |
14.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA134 |
muscleblind-like 2 (Drosophila) |
MBNL2 |
12.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA135 |
malate dehydrogenase 1, NAD (soluble) |
MDH1 |
4.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA136 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
ME3 |
5.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA137 |
family with sequence similarity 131, member A |
FAM131A |
10.0% Decrease Gene Expression Level |
brain |
Human |
|
DAA138 |
coiled-coil domain containing 46 |
CCDC46 |
86.0% Increase Gene Expression Level |
brain |
Human |
|
DAA139 |
megalencephalic leukoencephalopathy with subcortical cysts 1 |
MLC1 |
10.0% Increase Gene Expression Level |
brain |
Human |
|
DAA14 |
arylsulfatase A |
ARSA |
17.0% Increase Gene Expression Level |
brain |
Human |
|
DAA140 |
monocyte to macrophage differentiation-associated |
MMD |
7.0% Decrease Gene Expression Level |
brain |
Human |
|